+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Specialty Pharmaceuticals Market Research Report by Type (CNS, Infectious diseases, and Momen's health), Product, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4807792
  • Report
  • April 2022
  • Region: Global
  • 198 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • CIGNA Pharmacy Management
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Endo Pharmaceuticals Inc.
  • ENESI
  • Humana Pharmacy, Inc.
The Global Specialty Pharmaceuticals Market size was estimated at USD 47.47 billion in 2021, USD 66.24 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 39.69% to reach USD 352.89 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Specialty Pharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across CNS, Infectious diseases, Momen’s health, Oncology, and Respiratory.
  • Based on Product, the market was studied across Oral Pharmaceuticals, Parenteral Pharmaceuticals, and Transdermal Pharmaceuticals.
  • Based on Distribution Channel, the market was studied across Hospitals & Care Providers, Online Mode, Retail Pharmacies, and Specialty Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Specialty Pharmaceuticals market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Specialty Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Specialty Pharmaceuticals Market, including Accredo Health Group, Inc., Avella Specialty Pharmacy, Inc., CIGNA Pharmacy Management, CVS Health Corporation, Diplomat Pharmacy, Inc., Endo Pharmaceuticals Inc., ENESI, Humana Pharmacy, Inc., Hyphens Pharma Pte Ltd., Kroger Specialty Pharmacy, Inc., McKesson Corporation, Midatech Pharma PLC, UnitedHealth Group Incorporated, US WorldMeds, LLC, and Walgreens Boots Alliance, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Specialty Pharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Specialty Pharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Specialty Pharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Specialty Pharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Specialty Pharmaceuticals Market?
6. What is the market share of the leading vendors in the Global Specialty Pharmaceuticals Market?
7. What modes and strategic moves are considered suitable for entering the Global Specialty Pharmaceuticals Market?
Frequently Asked Questions about the Global Specialty Pharmaceuticals Market

What is the estimated value of the Global Specialty Pharmaceuticals Market?

The Global Specialty Pharmaceuticals Market was estimated to be valued at $47.5 Billion in 2021.

What is the growth rate of the Global Specialty Pharmaceuticals Market?

The growth rate of the Global Specialty Pharmaceuticals Market is 39.6%, with an estimated value of $352.9 Billion by 2027.

What is the forecasted size of the Global Specialty Pharmaceuticals Market?

The Global Specialty Pharmaceuticals Market is estimated to be worth $352.9 Billion by 2027.

Who are the key companies in the Global Specialty Pharmaceuticals Market?

Key companies in the Global Specialty Pharmaceuticals Market include Accredo Health Group, Inc., Avella Specialty Pharmacy, Inc., CIGNA Pharmacy Management, CVS Health Corporation, Diplomat Pharmacy, Inc., Endo Pharmaceuticals Inc., ENESI, Humana Pharmacy, Inc. and Kroger Specialty Pharmacy, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CIGNA Pharmacy Management
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Endo Pharmaceuticals Inc.
  • ENESI
  • Humana Pharmacy, Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for specialty drugs to treat complex or serious chronic conditions
5.1.1.2. Increased reimbursement through the medical benefit, and pharmacy benefit
5.1.1.3. Specialty pharmacy providers collaborating with pharma/biotech manufacturers, payers, MCOs and patients
5.1.1.4. Attractive prospects for biopharmaceutical companies from both business and medical innovation perspective
5.1.2. Restraints
5.1.2.1. Cost sharing discourages the use leading to adverse health outcomes
5.1.2.2. Growth in premium costs
5.1.3. Opportunities
5.1.3.1. Retailers involvements in specialty market and several chains operate their own specialty pharmacy divisions
5.1.3.2. Stimulated diagnostic research
5.1.3.3. Vendors offering compliance programs, reimbursement assistance programs and distribution channels
5.1.3.4. Growth of enhanced information technologies in the specialty sector
5.1.3.5. Value-added programs targeting physicians, nurses, patients and caregivers
5.1.4. Challenges
5.1.4.1. Less focus on development of low-cost generic equivalents of specialty drugs
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Specialty Pharmaceuticals Market, by Type
6.1. Introduction
6.2. CNS
6.3. Infectious diseases
6.4. Momen’s health
6.5. Oncology
6.6. Respiratory
7. Specialty Pharmaceuticals Market, by Product
7.1. Introduction
7.2. Oral Pharmaceuticals
7.3. Parenteral Pharmaceuticals
7.4. Transdermal Pharmaceuticals
8. Specialty Pharmaceuticals Market, by Distribution Channel
8.1. Introduction
8.2. Hospitals & Care Providers
8.3. Online Mode
8.4. Retail Pharmacies
8.5. Specialty Pharmacies
9. Americas Specialty Pharmaceuticals Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Specialty Pharmaceuticals Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Specialty Pharmaceuticals Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Accredo Health Group, Inc.
13.2. Avella Specialty Pharmacy, Inc.
13.3. CIGNA Pharmacy Management
13.4. CVS Health Corporation
13.5. Diplomat Pharmacy, Inc.
13.6. Endo Pharmaceuticals Inc.
13.7. ENESI
13.8. Humana Pharmacy, Inc.
13.9. Hyphens Pharma Pte Ltd.
13.10. Kroger Specialty Pharmacy, Inc.
13.11. McKesson Corporation
13.12. Midatech Pharma PLC
13.13. UnitedHealth Group Incorporated
13.14. US WorldMeds, LLC
13.15. Walgreens Boots Alliance, Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: DYNAMICS
FIGURE 2. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 16. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2027
FIGURE 18. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 25. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD BILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 27. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2019-2027 (USD BILLION)
FIGURE 28. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 29. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, 2019-2027 (USD BILLION)
FIGURE 30. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 32. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 33. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 34. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 35. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 36. ARGENTINA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 37. BRAZIL SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. CANADA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. MEXICO SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. AUSTRALIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. CHINA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. INDIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. INDONESIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. JAPAN SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. MALAYSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. PHILIPPINES SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. SINGAPORE SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. SOUTH KOREA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. TAIWAN SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. THAILAND SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. FRANCE SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. GERMANY SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. ITALY SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. NETHERLANDS SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. QATAR SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. RUSSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. SAUDI ARABIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. SOUTH AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. SPAIN SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. UNITED ARAB EMIRATES SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. UNITED KINGDOM SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 30. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, BY REGION, 2019-2027 (USD BILLION)
TABLE 31. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, BY STATE, 2019-2027 (USD BILLION)
TABLE 33. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, BY REGION, 2019-2027 (USD BILLION)
TABLE 36. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, BY STATE, 2019-2027 (USD BILLION)
TABLE 38. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 46. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 47. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 48. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 49. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 51. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, BY REGION, 2019-2027 (USD BILLION)
TABLE 52. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, BY STATE, 2019-2027 (USD BILLION)
TABLE 54. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 57. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 59. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 62. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 63. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 64. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 67. ARGENTINA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 68. BRAZIL SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 69. CANADA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 70. MEXICO SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 71. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. AUSTRALIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 74. CHINA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. INDIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. INDONESIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 77. JAPAN SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. MALAYSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. PHILIPPINES SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. SINGAPORE SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. SOUTH KOREA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. TAIWAN SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 83. THAILAND SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. FRANCE SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 86. GERMANY SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. ITALY SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. NETHERLANDS SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. QATAR SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. RUSSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. SAUDI ARABIA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. SOUTH AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. SPAIN SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. UNITED ARAB EMIRATES SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. UNITED KINGDOM SPECIALTY PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: SCORES
TABLE 97. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 98. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 99. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: RANKING
TABLE 100. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 101. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 102. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 103. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 104. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 105. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 106. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Accredo Health Group, Inc.
  • Avella Specialty Pharmacy, Inc.
  • CIGNA Pharmacy Management
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Endo Pharmaceuticals Inc.
  • ENESI
  • Humana Pharmacy, Inc.
  • Hyphens Pharma Pte Ltd.
  • Kroger Specialty Pharmacy, Inc.
  • McKesson Corporation
  • Midatech Pharma PLC
  • UnitedHealth Group Incorporated
  • US WorldMeds, LLC
  • Walgreens Boots Alliance, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...